Literature DB >> 7025910

A kinetic study on the mechanism of inhibition of RNA synthesis catalyzed by DNA-dependent RNA polymerase. Differences in inhibition by ethidium bromide, 3,8-diamino-6-ethylphenanthridinium bromide and actinomycin d.

S Aktipis, N Panayotatos.   

Abstract

The mechanism of inhibition of RNA polymerase-catalyzed synthesis of RNA by actinomycin D and the phenan-thridinium derivatives ethidium bromide and 3,8-diamino-6-ethylphenanthridinium bromide (DEMB) is examined. A general kinetic equation describing the dependence of RNA synthesis on DNA template concentration is derived and distinct expressions corresponding to various possible mechanisms of inhibition are subsequently obtained by introducing into the equations assumptions as appropriate for the individual mechanisms. The fitting of the experimental results of inhibition into the resulting equations suggested that the ethidium bromide and DEMB inhibit RNA polymerase by forming an inhibitor-template complex which interferes with enzyme recognition of, and binding to, appropriate sites on the template (binding inhibition). The fitting of the dependence of the rate of RNA synthesis on the bound-inhibitor to DNA ratios to the derived kinetic expressions also allows a tentative distinction to be made as to whether ethidium bromide and DEMB interfere with RNA synthesis by a mechanism of 'partial' or 'complete' inhibition.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7025910     DOI: 10.1016/0005-2787(81)90038-1

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  2 in total

1.  Application of SPLINDID, a semiparametric, model-based method for pharmacogenomic modeling of mRNA dynamics.

Authors:  Kavitha Bhasi; Alan Forrest; Murali Ramanathan
Journal:  Pharm Res       Date:  2006-03-24       Impact factor: 4.200

2.  A novel p70 S6 kinase-microRNA biogenesis axis mediates multicellular spheroid formation in ovarian cancer progression.

Authors:  Sophia So Ngo Lam; Carman Ka Man Ip; Abby Sin Chi Mak; Alice Sze Tsai Wong
Journal:  Oncotarget       Date:  2016-06-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.